Jazz Pharmaceuticals plans $1B note offering and share buyback

August 26, 2026 7:00 AM

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced that its wholly-owned subsidiary, Jazz Investments I Limited, intends to offer $1.0 billion in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found